Garden Stage updates F-3 prospectus disclosures
Garden Stage Limited filed a Form 6-K to correct cover-page disclosures in several 2025 prospectus supplements under its Form F-3 shelf.
Rhea-AI Filing Summary
Garden Stage Limited filed a Form 6-K to correct cover-page disclosures in several 2025 prospectus supplements under its Form F-3 shelf. The amendments restate language tied to General Instruction I.B.5 of Form F-3, which limits public primary offerings to no more than one-third of public float when that float is below $75,000,000.
The filing specifies that, for certain prior supplements, Garden Stage sold securities worth $1,489,999.50, $2,480,000, and $6,140,000 pursuant to Instruction I.B.5. It also clarifies that the public float was approximately $112,089,026.85 as of September 15, 2025, based on 64,393,265 ordinary shares held by non-affiliates at a Nasdaq closing price of $1.73 on July 17, 2025. The updated 6-K is incorporated by reference into the company’s effective Form F-3 and its Form S-8.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
General Instruction I.B.5. of Form F-3 regulatory
public primary offering financial
aggregate market value financial
public float financial
registration statement on Form F-3 regulatory
registration statement on Form S-8 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Garden Stage Limited (GSIW) report in this Form 6-K?
How much has Garden Stage (GSIW) sold under Form F-3 General Instruction I.B.5?
What public float does Garden Stage (GSIW) disclose in the 6-K?
How does General Instruction I.B.5 affect Garden Stage’s offerings?
Which registration statements incorporate this Garden Stage (GSIW) 6-K?
Does this Garden Stage (GSIW) 6-K change other prospectus supplement terms?
AI-generated analysis. How Rhea-AI works. Not financial advice.